PL-6983
Template:Short description Template:Short description <templatestyles src="Infobox drug/styles.css"/> Script error: No such module "Infobox".Template:Template otherScript error: No such module "TemplatePar".{{Infobox drug/maintenance categoriesTemplate:Yesno | drug_name = | INN = | _drugtype =
| _has_physiological_data= | _has_gene_therapy=
| vaccine_type= | mab_type= | _number_of_combo_chemicals=Script error: No such module "ParameterCount". | _vaccine_data= | _mab_data= | _mab_vaccine_data= | _mab_other_data= | _combo_data= | _physiological_data= | _clinical_data= Subcutaneous injectionMelanocortin MC4 receptor agonist | _legal_data=
| _other_data=
| _image_0_or_2 = | _image_LR =
| _datapage = PL-6983 (data page) | _vaccine_target=_type_not_vaccine | _legal_all= | _ATC_prefix_supplemental= | _has_EMA_link = | CAS_number=1966957-74-3 | PubChem= | ChemSpiderID= | ChEBI= | ChEMBL= | DrugBank= | KEGG= | _hasInChI_or_Key= | UNII= | _hasJmol02 = |_hasMultipleCASnumbers = |_hasMultiplePubChemCIDs = |_hasMultipleChEBIs =
| _countSecondIDs=Script error: No such module "ParameterCount". | _countIndexlabels=Script error: No such module "ParameterCount". | _trackListSortletter= |QID = |QID2 = |Verifiedfields= |Watchedfields= |verifiedrevid=}}
PL-6983 is a synthetic peptide and selective MC4 receptor agonist which is under development by Palatin Technologies for the treatment of female sexual dysfunction and erectile dysfunction.[1][2] It was developed as a successor to/replacement of bremelanotide (PT-141) due to concerns of the side effect of increased blood pressure seen with the latter in clinical trials.[1][2] Relative to bremelanotide, PL-6983 produces significantly lower increases in blood pressure in animal models.[1][2] The drug has reportedly been in pre-clinical development for all medical indications since 2008.[3] Palatin has stated that "We are focusing development efforts on bremelanotide for [female sexual dysfunction], but are continuing evaluation of PL-6983."[4] The chemical structure of PL-6983 has yet to be made public.
See also
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".
External links
- PL-6983 for Sexual Dysfunction - Palatin Technologies
- PL-6983 for Female Sexual Dysfunction - Palatin Technologies
- Palatin Obtains $21.1M to Advance Programs in Female Sexual Dysfunction and Asthma - Genetic Engineering and Biotechnology News
- Research Programme: Sexual Dysfunction Therapy (PL-6983) - Palatin Technologies - AdisInsight
- How Sildenax Works? Composition & Benefits of Sildenax - Nutri Medi
- How Medicines Work To Improve Potency - Vera FarmaciaTemplate:Category handler[<span title="Script error: No such module "string".">usurped]Script error: No such module "Check for unknown parameters".
Template:Sexual dysfunction pharmacotherapies Template:Melanocortin receptor modulators Template:Nervous-system-drug-stub